Axoral Capsules (200mg & 400mg) - Systemic Broad-Spectrum Antifungal Therapy

Product Overview

Axoral Capsules are a high-potency, broad-spectrum systemic antifungal formulation engineered to treat stubborn cutaneous, mucosal, and systemic fungal infections. Available in 200mg and 400mg strengths, Axoral effectively eradicates dermatophyte infections, yeast overgrowth, and resistant fungal strains that do not respond to topical therapy alone. By delivering targeted fungicidal action, Axoral provides comprehensive clinical relief for conditions such as severe tinea infections, resistant candidiasis, and onychomycosis, helping restore tissue health and preventing infection relapse.

Key Benefits

\n
• \n

  Broad-Spectrum Antifungal Coverage: Highly effective against dermatophytes (Trichophyton, Microsporum, Epidermophyton), Candida species, and various systemic fungi.

  \n
\n
• \n

  Flexible Clinical Dosing: Offered in 200mg and 400mg strengths to accommodate mild, moderate, and severe therapeutic regimens.

  \n
\n
• \n

  Deep Systemic Tissue Penetration: Reaches deep epidermal layers, nail beds, and mucosal surfaces where topical applications cannot penetrate.

  \n
\n
• \n

  Fast Symptom Relief: Rapidly halts fungal growth to relieve itching, inflammation, scaling, and skin discomfort.

  \n
\n
• \n

  Prevents Recrudescence: Eradicates deep-seated fungal spores to minimize the risk of infection recurrence.

  \n
\n

How It Works

Axoral Capsules operate by inhibiting the fungal cytochrome P450-dependent enzyme 14α-demethylase. This enzyme inhibition blocks the conversion of lanosterol to ergosterol—an essential component of the fungal cell membrane. The resulting depletion of ergosterol, combined with the accumulation of toxic methylated sterols, severely compromises fungal cell wall integrity and increases membrane permeability. This leads to cellular leakage, inhibition of fungal growth, and eventual cell death (fungicidal action).

WooCommerce Attribute / Variation Details

Variation 1: AXORAL CAPSULE 200MG

\n
• \n

  SKU: AXO-CAP-200

  \n
\n
• \n

  Short Description: Ideal for mild-to-moderate fungal infections, lower-weight patients, or step-down maintenance therapy.

  \n
\n
• \n

  Key Active Ingredient: Active Antifungal Agent — 200mg per capsule.

  \n
\n
• \n

  Target Indications: Tinea corporis, tinea cruris, oral candidiasis, and mild skin fungal conditions requiring systemic management.

  \n
\n
• \n

  Standard Dosage: Administer 200mg once daily with food, or as prescribed by a qualified healthcare professional.

  \n
\n

Variation 2: AXORAL CAPSULE 400MG

\n
• \n

  SKU: AXO-CAP-400

  \n
\n
• \n

  Short Description: High-strength formulation designed for severe, acute, or resistant systemic and deep-tissue fungal infections.

  \n
\n
• \n

  Key Active Ingredient: Active Antifungal Agent — 400mg per capsule.

  \n
\n
• \n

  Target Indications: Severe tinea pedis, onychomycosis (nail fungal infections), recalcitrant vaginal or systemic candidiasis.

  \n
\n
• \n

  Standard Dosage: Administer 400mg once daily (or split as directed) with food, or as prescribed by a medical specialist for high-burden infections.

  \n
\n

General Product Details (Shared across variations)

Key Active Ingredients

\n
• \n

  Broad-Spectrum Antifungal Agent (200mg / 400mg): Inhibits ergosterol synthesis in fungal cell membranes to eliminate fungal pathogens systemically.

  \n
\n

Directions for Use

\n
1. \n

   Administration: Take capsules whole with a full glass of water, ideally immediately after a main meal to maximize gastrointestinal absorption.

   \n
\n
2. \n

   Dosage: Select the appropriate strength (200mg or 400mg) based on the physician's prescription and clinical severity.

   \n
\n
3. \n

   Course Duration: Complete the full prescribed course of treatment even if symptoms improve early to prevent fungal resistance and relapse.

   \n
\n

Precautions

\n
• \n

  Prescription-Only: Must be administered under the guidance of a licensed healthcare provider.

  \n
\n
• \n

  Hepatic Monitoring: Exercise caution and monitor liver function tests in patients with pre-existing hepatic impairment or prolonged therapy.

  \n
\n
• \n

  Drug Interactions: Consult a physician regarding concurrent medications, especially antacids, anticoagulants, or drugs metabolized by cytochrome P450 pathways.

  \n
\n
• \n

  Pregnancy & Lactation: Consult a physician before use if pregnant, planning pregnancy, or breastfeeding.

  \n
\n
• \n

  Keep out of reach of children.

  \n
\n

Storage Instructions

Store in a cool, dry place below 30°C, protected from direct sunlight, heat, and moisture. Retain capsules in their original blister packaging until ingestion.

Manufacturer Information

Formulated and manufactured in strict compliance with international pharmaceutical quality standards, committed to engineering targeted anti-infective solutions that ensure superior patient recovery and clinical efficacy.